ILMN
42
5
DRI
53
5
CPB
30
6
NAVI
52
5
DE
63
3
CMG
72
5
ROK
62
15
EMN
60
4
NKE
36
6
SLB
55
2
F
58
11
FSLR
54
7
URI
65
5
EOG
58
2
ORCL
65
-2
SYY
53
4
LH
43
-2
BF.B
33
2
ACN
52
3
KLAC
47
4
ILMN
42
5
DRI
53
5
CPB
30
6
NAVI
52
5
DE
63
3
CMG
72
5
ROK
62
15
EMN
60
4
NKE
36
6
SLB
55
2
F
58
11
FSLR
54
7
URI
65
5
EOG
58
2
ORCL
65
-2
SYY
53
4
LH
43
-2
BF.B
33
2
ACN
52
3
KLAC
47
4
Financhill
Back

Altimmune Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70

ALT
Altimmune

Last Price:
8.66
Seasonality Move:
25.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 33.9% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $8.68. The Score for ALT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • ALT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 33.9% based on the past 19 years of stock performance.

Altimmune Stock Rating

Buy
70
Altimmune (ALT) is a Buy

Is Altimmune overpriced?

  • Altimmune has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.50

Prediction Charts

Market Cap:
617.36M
Price in USD:
8.68
Volume:
2.23M
Beta:
1.15

Technical Analysis

SMA50:
7.13
SMA100:
6.90
SMA200:
7.59
52-Wk Change:
239.06%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 8.68 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 6.76 7.03 7.03 6.64
Nov-6 7.26 7.31 7.41 7.08
Nov-7 7.75 7.46 8.05 7.40
Nov-8 7.45 7.68 7.68 7.37
Nov-11 7.89 7.35 7.96 6.92
Nov-12 7.62 9.49 10.02 7.46
Nov-13 9.75 9.51 11.16 9.46
Nov-14 9.55 8.46 9.70 8.33
Nov-15 8.27 7.61 8.54 7.46
Nov-18 7.55 7.15 7.59 6.95
Nov-19 7.04 7.47 7.48 6.98
Nov-20 7.61 8.05 8.42 7.52
Nov-21 8.06 8.41 9.06 7.91
Nov-22 8.42 8.68 8.84 8.28

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.23 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.